The study revealed that 14 percent of patients with
oropharyngeal cancers tested positive for HCV antibodies, compared to just 6.5 percent in the control group.
She later found that whereas from 1984 to 1989 in the U.S. only 16 percent of
oropharyngeal cancers tested positive for HPV, by 2005 that figure had skyrocketed to 73 percent.
Not exact matches
After medical
testing, doctors diagnosed him with stage four
oropharyngeal cancer.
Of note, 145 of all the
oropharyngeal cancer patients were also
tested for human papillomavirus (HPV), allowing researchers to compare possible associations between the two viruses.
Dr. Sturgis and his colleagues hope to provide data for such
tests in clinical trials that will screen people at high risk for HPV - related anal or
oropharyngeal cancers.